Tegaserod
FDA Approved
Contents
Description
Tegaserod is a serotonin-4 (5-HT4) receptor agonist used for the short-term treatment of irritable bowel syndrome with constipation (IBS-C) in women. It may be used off-label for intestinal benign neoplasm related constipation.
Indications & Therapeutic Use
Irritable bowel syndrome with constipation
Linked Diseases:
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Buy / Source Tegaserod — GNH India
4 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Tegaserod products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tegaserod
| Generic Name | Tegaserod |
| Brands | 1 brand available |
| Active Ingredient | Tegaserod |
| Drug Class | Irritable bowel syndrome with constipation |
| Manufacturer | Novartis |
| Dosage Forms | Tablet |
| Medical Code | A06AX04 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes